Horizon Pharma tries again to force special vote at target Depomed

• In the latest episode of the hostile takeover drama between Horizon Pharma (HZNP -0.6%) and its target, Depomed (DEPO -1.5%), Horizon has made a new SEC filing asking Depomed shareholders to call special meetings to dump the board.
• The two companies have engaged in repeated sniping about tactics as Depomed's board has rejected several offers to buy the company, and taken other measures including adopting a poison pill.
• Horizon's now appealing directly to shareholders to call for a prompt vote, hoping to elect its own slate, including Stanford law professor Robert Daines.
• Horizon holds about 2.25M shares of Depomed (about a 3.7% stake).
• Previous coverage of Horizon Pharma/Depomed